Artificial intelligence for antimicrobial resistance: advancing reproducibility, interpretability, and clinical
Sudipta Sardar1, Supriya Dash1, Puja Roychowdhury1
1Department of Bioinformatics, Pondicherry University, Kalapet, Puducherry 605014, India.
This review examines how to move computer-based tools for detecting drug-resistant infections from experimental settings into real-world hospital use. It outlines necessary standards for data quality, model transparency, and safety testing to ensure these tools help doctors make better prescribing decisions.
Area of Science:
- Computational biology and artificial intelligence for antimicrobial resistance research
- Clinical informatics and infectious disease diagnostics
Background:
No prior work has fully resolved the transition challenges for computational diagnostic tools in clinical settings. Researchers often struggle to bridge the gap between experimental performance and bedside utility. It was already known that early methods relied heavily on simple rule-based gene matching. Classical machine learning approaches later improved detection capabilities significantly. That uncertainty drove the need for more robust evaluation standards. Prior research has shown that data quality remains a significant hurdle for widespread adoption. This gap motivated a shift toward more transparent and reproducible modeling practices. The field now faces pressure to align technical outputs with patient safety requirements.
Purpose Of The Study:
The aim of this review is to establish a pragmatic standards framework for the clinical deployment of diagnostic models. The authors address the specific problem of transitioning experimental tools into reliable decision support systems. This motivation stems from the need to align computational outputs with antimicrobial stewardship goals. The researchers seek to define requirements for reproducibility and interpretability in healthcare settings. They identify a gap in current evaluation protocols regarding patient safety and error-cost trade-offs. The study intends to provide a clear roadmap for implementers to follow. By synthesizing existing evidence, the authors aim to improve the trustworthiness of these diagnostic systems. This work focuses on ensuring that accuracy leads to safer prescribing practices in hospitals.
Main Methods:
Review approach involves a systematic synthesis of the evolution of diagnostic modeling techniques. The authors analyze the progression from rule-based systems to modern generative architectures. This study evaluates current practices in dataset curation and validation protocols. The team examines existing healthcare guidelines to inform their proposed standards framework. They assess the integration of stewardship metrics within computational decision support systems. The methodology includes a critical review of error-cost analysis techniques for clinical safety. Researchers synthesize literature on federated learning and multimodal architectures. The approach provides a structured checklist for implementers based on current evidence.
Main Results:
Key findings from the literature indicate that clinical success hinges on rigorous reproducibility and interpretability standards. The review identifies that modern practice requires explicit bias and data-leakage audits for all models. Authors report that cost-sensitive evaluation is necessary to quantify the harms of incorrect predictions. The literature shows that integrating stewardship metrics like days of therapy improves clinical utility. Findings suggest that prospective temporal and external geographic validation are essential for reliable performance. The review highlights that generative models and foundation architectures offer new potential for peptide design. The analysis confirms that current governance-linked model cards are vital for transparency. The authors report that point-of-care explainability is a major factor for future adoption.
Conclusions:
The authors propose a comprehensive checklist to guide the implementation of diagnostic models in healthcare. Synthesis and implications suggest that FAIR data practices are necessary for long-term success. Researchers emphasize that multi-site validation is required to ensure generalizability across different populations. The review highlights that governance-linked model cards improve transparency for end users. Authors argue that stewardship-oriented error-cost trade-offs are vital for clinical safety. This synthesis indicates that prospective testing remains the gold standard for model evaluation. The team suggests that explainable interfaces will facilitate better adoption at the point of care. These findings provide a roadmap for creating trustworthy and deployable diagnostic systems.
Frequently Asked Questions
The researchers propose a framework emphasizing cost-sensitive evaluation, which quantifies the clinical harms of false-positive and false-negative results. This approach integrates stewardship metrics like time-to-effective therapy and spectrum narrowing to ensure that model accuracy translates into safer prescribing practices for patients.
The authors advocate for standardized model cards, which serve as transparent documentation for AI systems. These tools are designed to provide clear information regarding model development, limitations, and intended use, thereby facilitating better governance and accountability in clinical environments.
The authors state that multi-site external validation is necessary to ensure that models perform reliably across different geographic regions and patient populations. This process helps identify potential biases and data-leakage issues that might otherwise remain hidden during initial development.
The authors highlight that FAIR-aligned curation plays a role in ensuring data is findable, accessible, interoperable, and reusable. This data type is essential for building robust models that can be audited for bias and effectively integrated into existing healthcare infrastructures.
The authors discuss the phenomenon of data leakage, where information from the test set inadvertently influences model training. They propose explicit audits to detect this issue, ensuring that performance metrics accurately reflect the model's ability to generalize to new, unseen clinical data.
The researchers propose that explainable interfaces are poised to reshape the field by making complex model outputs understandable for clinicians. They claim these interfaces are necessary for successful integration at the point of care, where rapid and informed decision-making is required.
More Related Videos
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Automated Microbial Diagnostics
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Microbiota Modulation by Antibiotics
Antimicrobial Effectiveness
